MedPath

Microneedling Versus Carboxytherapy in Stria Distensae Rubra

Not Applicable
Active, not recruiting
Conditions
Striae Distensae
Registration Number
NCT07001644
Lead Sponsor
Alexandria University
Brief Summary

The aim of this study is to evaluate and compare the efficacy and safety of microneedling and carboxytherapy either with or without platelet-rich plasma in the treatment of striae distensae rubra.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Female patients.
  • Age ranging from 18-45 years old.
  • Fitzpatrick skin type III-IV.
  • Striae distensae rubra on the abdomen (bilateral and more or less symmetrical).
Exclusion Criteria
  • Patients taking immunosuppressants or having any disease affecting wound healing including diabetes.
  • Patients receiving systemic glucocorticoids for chronic health conditions.
  • Patients with chronic dermatologic diseases such as psoriasis and vitiligo.
  • Pregnant and lactating females.
  • Patients with a tendency for keloid formation.
  • Patients with endocrine disturbance.
  • Patients with autoimmune diseases, systemic diseases such as severe anemia, respiratory, cardiac, renal or liver disorder.
  • Patients with bleeding and coagulation disorders.
  • Patients who received any form of treatment for their SD in the past 6 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reduction in the size of the stria distensae rubragroup I: six sessions over 18 weeks , group II: 6 sessions over 12 weeks, followed in both groups by three months of follow up

will be assessed by digital photography, actual measurement of the stria before and after treatment, and objective assessment of the percent of improvement

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alexandria Faculty of Medicine

🇪🇬

Alexandria, Egypt

Alexandria Faculty of Medicine
🇪🇬Alexandria, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.